Platinum-based drugs contain coordinated complexes of platinum. These are widely used in the treatment of cancer as chemotherapeutic agents.
Platinum-based drugs contain coordinated complexes of platinum. These are widely used in the treatment of cancer as chemotherapeutic agents. Platinum acts as cell damaging agent for certain cancer treatments. Approximately 10% to 20% patients treated with chemotherapy receive platinum-based drugs. These drugs are used either alone or in combination with other drug treatment. Rise in prevalence of cancer is a major driver of the global platinum-based drugs market. According to the National Cancer Institute, the number of new cancer cases per year is expected to rise to 23.6 million by 2030. However, side effects associated with the drugs and development of resistance for the drug are the major restraints of the global platinum-based drugs market. Recent trends in platinum-based drugs include development of platinum drugs analog such as platinum complexes with carrier molecule in order to increase targeted concentration of drug in cancer tumor.
Request Brochure of Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=52662
The global platinum-based drugs market can be segmented based on product type and application. In terms of product type, the platinum-based drugs market can be classified into cisplatin, carboplatin, oxaliplatin, and others. Cisplatin is the most common platinum-based drug used in the treatment of certain malignancies. It is particularly effective in testicular cancer and is administered intravenously. Carboplatin, a derivative of cisplatin, is used to treat various cancers including ovarian, lung, brain, and others. Oxaliplatin is used in colorectal cancer and usually administered in combination with other chemotherapeutic agents. It is used primarily for cancers that do not respond to cisplatin. The Cisplatin segment held the largest share of the market in 2017 and is expected to sustain its leadership position during the forecast period. Based on application, the global platinum-based drugs market can be divided into testicular cancer, ovarian cancer, colorectal cancer, lung cancer, and others. The lung cancer segment dominated the market in 2017 due to high prevalence of lung cancer among the global population. According to the WHO, cancer is the second leading cause of death globally, and accounts for an estimated 9.6 million deaths in 2018, including lung cancer accounting for 2.09 million cases. The segment is expected to continue to dominate the market from 2018 to 2026.
Request for Analysis of COVID-19 Impact on Platinum-based Drugs Market –
https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=52662
In terms of region, the global platinum-based drugs market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominated the global market in 2017 due to high prevalence of cancer in the region, developments in platinum-based drugs, and recent FDA approvals. According to the National Cancer Institute, an estimated 1,735,350 new cases of cancer will be diagnosed in the U.K. and 609,640 people will succumb to the disease in 2018. The market in Asia Pacific is anticipated to expand at the highest CAGR owing to rise in prevalence of diseases, surge in awareness, increase in per capita income, and improvement in health care infrastructure.
Pre book Platinum-based Drugs Market Report at https://www.transparencymarketresearch.com/checkout.php?rep_id=52662<ype=S
Major players operating in the platinum-based drugs market include Pfizer, Inc., Sanofi, Ask-Pharma, Mylan N.V., Sun Pharmaceutical Industries Ltd., Novartis AG, Accord Healthcare, Guizhou YiBai Pharmaceutical Co., Ltd., Teva Pharmaceutical Industries Ltd., Qilu Pharmaceutical Co., Ltd., SK Chemicals, Debiopharm Group, Dr. Reddy’s Laboratories Ltd., and Jiangsu Hengrui Pharmaceutical Co., Ltd.
Read more information here:
https://www.transparencymarketresearch.com/platinum-based-drugs-market.html
The following regional segments are covered comprehensively:
- North America
- Asia Pacific
- Europe
- Latin America
- The Middle East and Africa
Top of Form
Ask for Discount :
https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=52662
About Us
Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.
Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through ad hoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.
TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.
Contact
Mr. Rohit Bhisey
Transparency Market Research
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
USA - Canada Toll Free: 866-552-3453